BCR : Analysis & Opinions

  1. It Gets A Little Harder From Here For Covidien

    April 29, 2013
    Expectations are the bigger issue for Covidien, as underlying growth is still pretty good on a relative basis.
  2. AngioDynamics Still Struggling To Get Back On Track

    April 10, 2013
    Ongoing revenue growth struggles and eroding market share is making the deep-value case harder at AngioDynamics.
  3. Endo Health Solutions Needs Some Solutions Of Its Own

    November 7, 2012
    Can Endo reestablish itself as a quality healthcare name?
  4. Becton Dickinson Safe And Steady

    June 13, 2012
    Becton stands out for having one of the clearest growth strategies in its field as well as a solid track record of delivering ...
  5. Covidien Reports, Ready To Spin Off Pharma

    May 4, 2012
    Covidien is looking to bridge its current valuation discount with a number of purer-play rivals.
  6. CareFusion: Is It Still Cheap?

    May 3, 2012
    The biggest concern investors have with CareFusion is its low return on invested capital. Until it creates higher free cash ...
  7. Modest But Predictable Growth At C.R. Bard

    April 26, 2012
    C.R. Bard is posting modest operational growth but there is ample downside protection.
  8. 2011 - Another Sick Year For Larger Med-Tech

    December 29, 2011
    Larger healthcare companies are still getting sickly returns in the market.
  9. Covidien Delivers Once Again

    November 21, 2011
    Covidien is overlooked and undervalued.
  10. Is Hologic A Coiled Spring?

    November 11, 2011
    Hologic looks cheap on even modest growth recovery expectations.
  11. If CareFusion Can Execute, This Is A Major Bargain

    November 9, 2011
    CareFusion has to make some improvements, but it could really reward investors.
  12. Endo And Forest – Dumpster-Diving In Pharma

    September 21, 2011
    Endo and Forest have problems; however, the valuations seem excessively low.
  13. BD Healthy, But No Great Bargain

    August 9, 2011
    BD is not the cheapest health care name, but it comes with a lot of quality.
  14. Covidien's Image Starting To Change

    August 3, 2011
    Find out why Covidien is much better than many investors assume.
  15. Heavily Shorted Stocks Near Their Highs

    March 21, 2011
    When hot stocks have high short interest, investors should pause and reexamine their thesis.
  16. Money To Be Made In Medical Devices

    September 22, 2010
    New advances in medical devices will not only help patients live better lives, but they'll power portfolios as well.
  17. Covidien Happy With Tyco Split

    March 3, 2010
    Projections for double-digit profit increases at Covidien would easily take care of any valuation concerns at current levels.
  18. Mid Cap Stocks That Have Been Left Behind

    May 15, 2009
    Despite the huge market rally over the last two months, there are several mid cap stocks that have not participated. Investors ...
  19. Mileage Matters More Than Muscle

    March 26, 2008
    Sometimes consistency produces better returns than undependable potential. Medical equipment company C.R. Bard is proof.
Trading Center